Thursday May 25th 2017

Posts Tagged ‘Sense Of Urgency’

Multiple Sclerosis: CCSVI and the liberation procedure; Advocacy for Paolo Zamboni

Multiple Sclerosis: CCSVI and the liberation procedure; Advocacy for Paolo Zamboni

URGENT: IF YOU OR SOMEONE YOU LOVE SUFFERS FROM MS, IT IS IMPORTANT TO RESEARCH AND INFORM OTHERS OF THE LIBERATION PROCEDURE AND A DISEASE CALLED CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY. THIS DISEASE SHOWS STRONG EMPIRICAL EVIDENCE TO CAUSE THE DESTRUCTIVE DISEASE KNOWN [Read More]

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]